Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Neurodegenerative Disease

PUBLISHER: Grand View Research | PRODUCT CODE: 1630989

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1630989

Sclerotherapy Market Size, Share & Trends Analysis Report By Agents (Detergents, Chemical Irritants, Osmotic Agents), By Type (Ultrasound Sclerotherapy), By Application, By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Sclerotherapy Market Growth & Trends:

The global sclerotherapy market size is estimated to reach USD 1.50 billion by 2030, expanding at a CAGR of 4.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. Sclerotherapy is a non-invasive procedure that is widely used as a primary treatment for reticular veins, leg telangiectasias, and varicose veins. The procedure comprises injecting a solution (sclerosing agents or sclerosants) straight into the affected veins, which causes them to shrink and eventually disappear and assist in treating related symptoms such as aching, burning, swelling, and cramping. Factors like the better exposure to the site of application, utilization of less-invasive technologies, advances in dermatology, and increasing geriatric population with an incidence of varicose veins are fuelling the market growth.

Sclerosing agents used for the treatment of varicose veins are segmented into detergents, hyperosmolar/ osmotic agents, and chemical irritants. Agents like Sodium tetradecyl sulfate (Sotradecol) and Polidocanol (Asclera), Sodium morrhuate (Scleromate), Ethanolamine Oleate (Ethamoline) are all FDA approved sclerosants used to treat and reduce the effect of vein damage. According to the Society of Vascular surgery, more than 33.0% of women and about 17.0% of men consult a doctor for telangiectasias and varicose veins in industrialized countries, affecting up to 35.0% of people in the U.S. alone.

This condition, if left untreated can cause severe health problems such as chronic pain, deep vein clots, skin ulcers, and coronary ailments. According to NCBI, 20.0% of all adults will get varicose veins at some point in their lives and the prevalence is higher among the aging population and women. These factors are expected to boost the market growth. However, the side effects of this procedure such as hyperpigmentation and matting, scarring, and allergic reactions in some patients might hinder the market growth.

Sclerotherapy Market Report Highlights:

  • The detergents segment dominated the market with a revenue share of 43.5% in 2024 owing to high approvals by the FDA, low risk of clot formation, effectiveness, and its popularity among doctors
  • The foam sclerotherapy segment is anticipated to grow fast over the forecast period due to better exposure to the onsite and results than liquid sclerotherapy
  • North America sclerotherapy market dominated the global with a revenue share of 44.5% in 2024 owing to increasing demand for new technologies, a large pool of key players, rising prevalence of varicose veins, and advanced healthcare infrastructure in the region
  • Asia Pacific sclerotherapy market is expected to register the highest CAGR of 5.7% over the forecast period
Show more
Product Code: GVR-4-68039-010-4

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Agents
    • 1.2.2. Type
    • 1.2.3. Application
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Sclerotherapy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Sclerotherapy Market: Agents Business Analysis

  • 4.1. Agents Market Share, 2024 & 2030
  • 4.2. Agents Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Agents, 2018 to 2030 (USD Billion)
  • 4.4. Detergents
    • 4.4.1. Detergents Market, 2018 - 2030 (USD Billion)
  • 4.5. Chemical Irritants
    • 4.5.1. Chemical Irritants Market, 2018 - 2030 (USD Billion)
  • 4.6. Osmotic Agents
    • 4.6.1. Osmotic Agents Market, 2018 - 2030 (USD Billion)

Chapter 5. Sclerotherapy Market: Type Business Analysis

  • 5.1. Type Market Share, 2024 & 2030
  • 5.2. Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Billion)
  • 5.4. Ultrasound Sclerotherapy
    • 5.4.1. Ultrasound Sclerotherapy Market, 2018 - 2030 (USD Billion)
  • 5.5. Liquid Sclerotherapy
    • 5.5.1. Liquid Sclerotherapy Market, 2018 - 2030 (USD Billion)
  • 5.6. Foam Sclerotherapy
    • 5.6.1. Foam Sclerotherapy Market, 2018 - 2030 (USD Billion)

Chapter 6. Sclerotherapy Market: Application Business Analysis

  • 6.1. Application Market Share, 2024 & 2030
  • 6.2. Application Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Billion)
  • 6.4. Varicose Veins
    • 6.4.1. Varicose Veins Market, 2018 - 2030 (USD Billion)
  • 6.5. Malformed Lymph Vessels
    • 6.5.1. Malformed Lymph Vessels Market, 2018 - 2030 (USD Billion)
  • 6.6. Hemorrhoids
    • 6.6.1. Hemorrhoids Market, 2018 - 2030 (USD Billion)
  • 6.7. Hydroceles
    • 6.7.1. Hydroceles Market, 2018 - 2030 (USD Billion)

Chapter 7. Sclerotherapy Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Sclerotherapy Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Europe
    • 7.5.1. Europe Sclerotherapy Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Sclerotherapy Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7. Latin America
    • 7.7.1. Latin America Sclerotherapy Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.3. Mexico
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Mexico Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.4. Argentina
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Framework
      • 7.7.4.3. Competitive Insights
      • 7.7.4.4. Argentina Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8. MEA
    • 7.8.1. MEA Sclerotherapy Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Sclerotherapy Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. LGM Pharma
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Agents Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Troikaa
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Agents Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Viatris Inc.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Agents Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Omega Pharmaceuticals Pvt. Ltd.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Agents Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Merz Pharma
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Agents Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. ENDO-FLEX GmbH.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Agents Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Perrigo Company plc
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Agents Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Medi-Globe GmbH
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Agents Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Medtronic
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Agents Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. AngioDynamics
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Agents Benchmarking
      • 8.5.10.4. Strategic Initiatives
Show more
Product Code: GVR-4-68039-010-4

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global sclerotherapy market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 5 Global sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 6 Global sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 7 North America sclerotherapy market, by country, 2018 - 2030 (USD Billion)
  • Table 8 North America sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 9 North America sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 10 North America sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 11 U.S. sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 12 U.S. sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 13 U.S. sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 14 Canada sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 15 Canada sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 16 Canada sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 17 Europe sclerotherapy market, by country, 2018 - 2030 (USD Billion)
  • Table 18 Europe sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 19 Europe sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 20 Europe sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 21 UK sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 22 UK sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 23 UK sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 24 Germany sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 25 Germany sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 26 Germany sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 27 France sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 28 France sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 29 France sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 30 Italy sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 31 Italy sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 32 Italy sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 33 Spain sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 34 Spain sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 35 Spain sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 36 Norway sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 37 Norway sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 38 Norway sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 39 Denmark sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 40 Denmark sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 41 Denmark sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 42 Sweden sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 43 Sweden sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 44 Sweden sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 45 Asia Pacific sclerotherapy market, by country, 2018 - 2030 (USD Billion)
  • Table 46 Asia Pacific sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 47 Asia Pacific sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 48 Asia Pacific sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 49 Japan sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 50 Japan sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 51 Japan sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 52 China sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 53 China sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 54 China sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 55 India sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 56 India sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 57 India sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 58 Australia sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 59 Australia sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 60 Australia sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 61 South Korea sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 62 South Korea sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 63 South Korea sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 64 Thailand sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 65 Thailand sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 66 Thailand sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 67 Latin America sclerotherapy market, by country, 2018 - 2030 (USD Billion)
  • Table 68 Latin America sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 69 Latin America sclerotherapy market, by type, 2018 - 2030 (USD Billion
  • Table 70 Latin America sclerotherapy market, by application, 2018 - 2030 (USD Billion
  • Table 71 Brazil sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 72 Brazil sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 73 Brazil sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 74 Mexico sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 75 Mexico sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 76 Mexico sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 77 Argentina sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 78 Argentina sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 79 Argentina sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 80 Middle East & Africa sclerotherapy market, by country, 2018 - 2030 (USD Billion)
  • Table 81 Middle East & Africa sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 82 Middle East & Africa sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 83 Middle East & Africa sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 84 South Africa sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 85 South Africa sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 86 South Africa sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 87 Saudi Arabia sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 88 Saudi Arabia sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 89 Saudi Arabia sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 90 UAE sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 91 UAE sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 92 UAE sclerotherapy market, by application, 2018 - 2030 (USD Billion)
  • Table 93 Kuwait sclerotherapy market, by agents, 2018 - 2030 (USD Billion)
  • Table 94 Kuwait sclerotherapy market, by type, 2018 - 2030 (USD Billion)
  • Table 95 Kuwait sclerotherapy market, by application, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Sclerotherapy market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Agents outlook (USD Billion)
  • Fig. 10 Type outlook (USD Billion)
  • Fig. 11 Application outlook (USD Billion)
  • Fig. 12 Competitive landscape
  • Fig. 13 Sclerotherapy market dynamics
  • Fig. 14 Sclerotherapy market: Porter's five forces analysis
  • Fig. 15 Sclerotherapy market: PESTLE analysis
  • Fig. 16 Sclerotherapy market: Agents segment dashboard
  • Fig. 17 Sclerotherapy market: Agents market share analysis, 2024 & 2030
  • Fig. 18 Detergents market, 2018 - 2030 (USD Billion)
  • Fig. 19 Chemical irritants market, 2018 - 2030 (USD Billion)
  • Fig. 20 Osmotic agents market, 2018 - 2030 (USD Billion)
  • Fig. 21 Sclerotherapy market: Type segment dashboard
  • Fig. 22 Sclerotherapy market: Type market share analysis, 2024 & 2030
  • Fig. 23 Ultrasound sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 24 Liquid sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 25 Foam sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 26 Sclerotherapy market: Application segment dashboard
  • Fig. 27 Sclerotherapy market: Application market share analysis, 2024 & 2030
  • Fig. 28 Varicose veins market, 2018 - 2030 (USD Billion)
  • Fig. 29 Malformed lymph vessels market, 2018 - 2030 (USD Billion)
  • Fig. 30 Hemorrhoids market, 2018 - 2030 (USD Billion)
  • Fig. 31 Hydroceles market, 2018 - 2030 (USD Billion)
  • Fig. 32 Sclerotherapy market revenue, by region
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 North America sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 35 U.S. country dynamics
  • Fig. 36 U.S. sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 37 Canada country dynamics
  • Fig. 38 Canada sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 39 Europe sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 40 UK country dynamics
  • Fig. 41 UK sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 42 Germany country dynamics
  • Fig. 43 Germany sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 44 France country dynamics
  • Fig. 45 France sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 46 Italy country dynamics
  • Fig. 47 Italy sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 48 Spain country dynamics
  • Fig. 49 Spain sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 50 Norway country dynamics
  • Fig. 51 Norway sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 52 Denmark country dynamics
  • Fig. 53 Denmark sclerotherapy market, 2018 - 2030 (USD Billion
  • Fig. 54 Sweden country dynamics
  • Fig. 55 Sweden sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 56 Asia Pacific sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 57 Japan country dynamics
  • Fig. 58 Japan sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 59 China country dynamics
  • Fig. 60 China sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 61 India country dynamics
  • Fig. 62 India sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 63 South Korea country dynamics
  • Fig. 64 South Korea sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 65 Australia country dynamics
  • Fig. 66 Australia sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 67 Thailand country dynamics
  • Fig. 68 Thailand sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 69 Latin America sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 70 Brazil country dynamics
  • Fig. 71 Brazil sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 72 Mexico country dynamics
  • Fig. 73 Mexico sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 74 Argentina country dynamics
  • Fig. 75 Argentina sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 76 MEA sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 77 South Africa country dynamics
  • Fig. 78 South Africa sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 79 Saudi Arabia country dynamics
  • Fig. 80 Saudi Arabia sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 81 UAE country dynamics
  • Fig. 82 UAE sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 83 Kuwait country dynamics
  • Fig. 84 Kuwait sclerotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 85 Company categorization
  • Fig. 86 Company market position analysis
  • Fig. 87 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!